The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

NASACORT 55 micrograms/dose, nasal spray, suspension

Opella Healthcare France SAS T/A SanofiPA23180/001/001

Main Information

Trade NameNASACORT 55 micrograms/dose, nasal spray, suspension
Active SubstancesTriamcinolone acetonide
Dosage FormNasal spray, suspension
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/001/001

Group Information

ATC CodeR01AD Corticosteroids
R01AD11 triamcinolone


License statusAuthorised
Licence Issued06/02/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back